Lbp Am Sa Acquires 21,528 Shares of Axon Enterprise, Inc $AXON

Lbp Am Sa grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 603.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 25,097 shares of the biotechnology company’s stock after acquiring an additional 21,528 shares during the quarter. Lbp Am Sa’s holdings in Axon Enterprise were worth $14,253,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. Equity Wealth Partners LLC raised its position in Axon Enterprise by 2.4% during the fourth quarter. Equity Wealth Partners LLC now owns 1,553 shares of the biotechnology company’s stock valued at $882,000 after purchasing an additional 36 shares during the period. PFG Investments LLC raised its holdings in Axon Enterprise by 2.6% during the 4th quarter. PFG Investments LLC now owns 3,866 shares of the biotechnology company’s stock valued at $2,196,000 after buying an additional 98 shares during the period. Farther Finance Advisors LLC lifted its position in Axon Enterprise by 6.5% in the fourth quarter. Farther Finance Advisors LLC now owns 8,233 shares of the biotechnology company’s stock worth $4,676,000 after buying an additional 505 shares during the last quarter. Tyche Wealth Partners LLC lifted its position in Axon Enterprise by 1.3% in the fourth quarter. Tyche Wealth Partners LLC now owns 1,922 shares of the biotechnology company’s stock worth $1,091,000 after buying an additional 25 shares during the last quarter. Finally, Oak Ridge Investments LLC boosted its stake in Axon Enterprise by 4.2% during the fourth quarter. Oak Ridge Investments LLC now owns 16,388 shares of the biotechnology company’s stock worth $9,307,000 after buying an additional 660 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer owned 3,090,997 shares in the company, valued at $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider owned 55,588 shares of the company’s stock, valued at $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 13,855 shares of company stock worth $7,109,828. Company insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. Needham & Company LLC lowered their target price on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday, February 20th. UBS Group decreased their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. TD Cowen cut their target price on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Royal Bank Of Canada decreased their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. Finally, Weiss Ratings downgraded Axon Enterprise from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, April 10th. Sixteen analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $749.63.

Axon Enterprise Trading Down 2.3%

NASDAQ:AXON opened at $393.08 on Friday. The firm has a 50-day simple moving average of $460.29 and a 200-day simple moving average of $557.38. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The firm has a market cap of $31.60 billion, a P/E ratio of 258.61, a P/E/G ratio of 8.58 and a beta of 1.61. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise’s revenue was up 38.5% compared to the same quarter last year. During the same period last year, the company posted $2.08 earnings per share. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.